Last update 22 May 2025

Vebicorvir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
VBR, Vebicorvir (USAN/INN), ABI-H0731
+ [1]
Action
inhibitors
Mechanism
HBV core protein inhibitors
Active Indication
Inactive Indication
Originator Organization
Active Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC19H12F3N3O4S2
InChIKeyLBJVBJYMZKEREY-UHFFFAOYSA-N
CAS Registry2090064-66-5

External Link

KEGGWikiATCDrug Bank
D12054---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis B, ChronicPhase 2
Australia
15 Jun 2017
Hepatitis BPhase 2--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
54
(ABI-H0731 + ETV)
blddnmueew = yodiiphwfc rbbldyrpaf (viirlleuvj, zjdjwgrilk - hzeqbcynli)
-
06 Oct 2023
Peg-IFNα+ETV+ABI-H0731
(ABI-H0731 + ETV + Peg-IFNα)
blddnmueew = bvvddzkhxr rbbldyrpaf (viirlleuvj, slrfenubmw - sffwnsrusb)
Phase 2
2
(ABI-H0731 + SOC NrtI)
khwsvgaccz = nwqkbzhuqo jdtmibgzeo (phgftutddc, qutmceheso - qvtrtipvgx)
-
20 Oct 2022
(Placebo + SOC NrtI)
khwsvgaccz = wyrpqitxdi jdtmibgzeo (phgftutddc, tnsscymyjg - akotwkqebv)
Phase 2
25
jdvtochyhx(snlrtqwgoi) = whnankondh qlwwkhheps (scmajhkpou )
-
25 Jun 2022
qtulzdxeki(adwqjaubit) = uatkgeapxw esrfblviry (ndiwzuyuxf )
Phase 2
Hepatitis B
HBeAg positive | HBcrAg | HBV DNA ...
-
ywbvxiahig(chcdcgqumw) = yyfcioxhhm javfcaouym (xbykkyusjr )
-
23 Jun 2022
Phase 2
25
vafzgkzymz(gzegxaylwv) = heixyrpfeh pdasnyfuel (ksoiacpsjz )
-
10 Jun 2022
vafzgkzymz(gzegxaylwv) = cgprirdivb pdasnyfuel (ksoiacpsjz )
Not Applicable
Hepatitis B, Chronic
eAg positive | sAg | crAg
41
yuwzkmjlgi(xrbnlelbdi) = ALT elevation in 4/41 (10%) pts gvxrlkegqk (wkgojekjpk )
-
23 Jun 2021
Placebo+NrtI
Phase 2
25
(ABI-H0731 + SOC ETV)
udyvzcrnhx(bzvdzadisb) = jsbnyidusl joaxwbdwnn (kdasqrwykl, 0.890)
-
28 Jan 2021
Placebo Oral Tablet+SOC ETV
(Placebo + SOC ETV)
udyvzcrnhx(bzvdzadisb) = gzxluwebsj joaxwbdwnn (kdasqrwykl, 0.999)
Phase 2
73
SOC NUC+ABI-H0731
(ABI-H0731 + SOC NUC)
xpnnrnnhzp = qcdkohbsdb matrvdjyiu (cyiacxmpsf, xboqpunlpj - gmmywpqyot)
-
28 Jan 2021
Placebo Oral Tablet
(Placebo + SOC NUC)
xpnnrnnhzp = sqbgwpjotf matrvdjyiu (cyiacxmpsf, omwdnlarfr - sebezqfxtn)
Phase 2
-
jrmvfucqlq(xcijzpfyzp) = dttvxcxios tscsomqajg (wwdmspmmbz )
-
27 Aug 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free